Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.

Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M, Holtzman DM.

Mol Neurodegener. 2014 Jun 3;9:20. doi: 10.1186/1750-1326-9-20.

2.

Association of Alzheimer's Disease With APOE and IL-1α Gene Polymorphisms.

Yildiz SH, Erdogan MO, Artan S, Solak M, Yaman M, Ozbabalik BD, Terzi ES.

Am J Alzheimers Dis Other Demen. 2015 Dec;30(8):756-61. doi: 10.1177/1533317512461557. Epub 2012 Oct 4.

PMID:
23038715
3.

A polymorphism in the upstream regulatory region of the interleukin-1α gene confers differential binding by transcription factors of the AP-1 family.

Moerman-Herzog AM, Barger SW.

Life Sci. 2012 Jun 27;90(25-26):975-9. doi: 10.1016/j.lfs.2012.05.004. Epub 2012 May 23.

4.

Interactions between PPAR-α and inflammation-related cytokine genes on the development of Alzheimer's disease, observed by the Epistasis Project.

Heun R, Kölsch H, Ibrahim-Verbaas CA, Combarros O, Aulchenko YS, Breteler M, Schuur M, van Duijn CM, Hammond N, Belbin O, Cortina-Borja M, Wilcock GK, Brown K, Barber R, Kehoe PG, Coto E, Alvarez V, Lehmann MG, Deloukas P, Mateo I, Morgan K, Warden DR, Smith AD, Lehmann DJ.

Int J Mol Epidemiol Genet. 2012;3(1):39-47. Epub 2012 Feb 23.

5.

The association of genetic variants in interleukin-1 genes with cognition: findings from the cardiovascular health study.

Benke KS, Carlson MC, Doan BQ, Walston JD, Xue QL, Reiner AP, Fried LP, Arking DE, Chakravarti A, Fallin MD.

Exp Gerontol. 2011 Dec;46(12):1010-9. doi: 10.1016/j.exger.2011.09.005. Epub 2011 Sep 24.

6.

Decreased mRNA expression of CCL5 [RANTES] in Alzheimer's disease blood samples.

Kester MI, van der Flier WM, Visser A, Blankenstein MA, Scheltens P, Oudejans CB.

Clin Chem Lab Med. 2011 Sep 23;50(1):61-5. doi: 10.1515/CCLM.2011.731.

PMID:
21942811
7.

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease.

Lauterbach EC.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):1-7. doi: 10.1097/WAD.0b013e318214b7d0. Review.

PMID:
21399480
8.

The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Combarros O, Warden DR, Hammond N, Cortina-Borja M, Belbin O, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Barber R, Coto E, Alvarez V, Deloukas P, Gwilliam R, Heun R, Kölsch H, Mateo I, Oulhaj A, Arias-Vásquez A, Schuur M, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Morgan K, Smith AD, Lehmann DJ.

BMC Med Genet. 2010 Nov 11;11:162. doi: 10.1186/1471-2350-11-162.

9.

Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.

Laumet G, Chouraki V, Grenier-Boley B, Legry V, Heath S, Zelenika D, Fievet N, Hannequin D, Delepine M, Pasquier F, Hanon O, Brice A, Epelbaum J, Berr C, Dartigues JF, Tzourio C, Campion D, Lathrop M, Bertram L, Amouyel P, Lambert JC.

J Alzheimers Dis. 2010;20(4):1181-8. doi: 10.3233/JAD-2010-100126.

PMID:
20413850
10.

No replication of genetic association between candidate polymorphisms and Alzheimer's disease.

Cousin E, Macé S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Génin E, Brice A, Campion D.

Neurobiol Aging. 2011 Aug;32(8):1443-51. doi: 10.1016/j.neurobiolaging.2009.09.004. Epub 2009 Nov 3.

PMID:
19889475
11.

Lack of association between interleukin-1 alpha rs1800587 polymorphism and Alzheimer's disease in two Independent European samples.

Serretti A, Olgiati P, Politis A, Malitas P, Albani D, Dusi S, Polito L, De Mauro S, Zisaki A, Piperi C, Liappas I, Stamouli E, Mailis A, Atti AR, Morri M, Ujkaj M, Batelli S, Forloni G, Soldatos CR, Papadimitriou GN, De Ronchi D, Kalofoutis A.

J Alzheimers Dis. 2009;16(1):181-7. doi: 10.3233/JAD-2009-0946.

PMID:
19158434
12.

C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.

Wei X, Chen X, Fontanilla C, Zhao L, Liang Z, Dodel R, Hampel H, Farlow M, Du Y.

Life Sci. 2007 Feb 27;80(12):1152-6. Epub 2006 Dec 23.

13.

Pharmacogenomics for the treatment of dementia.

Cacabelos R.

Ann Med. 2002;34(5):357-79. Review.

PMID:
12452480
14.

Pharmacogenomics in Alzheimer's disease.

Cacabelos R.

Mini Rev Med Chem. 2002 Feb;2(1):59-84. Review.

PMID:
12369958
15.

Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease.

Pirskanen M, Hiltunen M, Mannermaa A, Iivonen S, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M, Soininen H, Alafuzoff I.

Dement Geriatr Cogn Disord. 2002;14(3):123-7.

PMID:
12218254
16.

Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.

Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nägga K, Bogdanovic N, Blennow K, Brookes AJ.

Eur J Hum Genet. 2001 Jun;9(6):437-44.

Supplemental Content

Loading ...
Support Center